When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Aurinia Pharma press release ( NASDAQ: AUPH ): Q4 GAAP EPS of -$0.18 beats by $0.09 .
Revenue of $28.4M (+21.4% Y/Y) misses by $0.42M .
Cash, cash equivalents, and investments of $389.4 million as of December 31, 2022.
For fiscal year 2023, the Company is reiterating its previous net product revenue guidance of $120 to $140 million from sales of LUPKYNIS. This range represents a double-digit percentage increase in net product revenue from sales of LUPKYNIS compared to fiscal year 2022.